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Abstract
In preparation for vaccine trials, HIV-1 genetic diversity was surveyed between 2002 and 2006 through the
Cohort Development study in the form of a retrospective and prospective observational study in and around the
town of Mbeya in Tanzania’s Southwest Highlands. This study describes the molecular epidemiology of HIV-1
strains obtained from 97 out of 106 incident HIV-1 infections identified in three subpopulations of participants
(one rural, two urban) from the Mbeya area. Near full-genome or half-genome sequencing showed a subtype
distribution of 40% C, 17% A1, 1% D, and 42% inter-subtype recombinants. Compared to viral subtyping
results previously obtained from the retrospective phase of this study, the overall proportion of incident viral
strains did not change greatly during the study course, suggesting maturity of the epidemic. A comparison to a
current Phase I-II vaccine being tested in Africa shows *17% amino acid sequence difference between the
gp120 of the vaccine and subtype C incident strains. Phylogenetic and recombinant breakpoint analysis of the
incident strains revealed the emergence of CRF41_CD and many unique recombinants, as well as the presence
of six local transmission networks most of which were confined to the rural subpopulation. In the context of
vaccine cohort selection, these results suggest distinct infection transmission dynamics within these three
geographically close subpopulations. The diversity and genetic sequences of the HIV-1 strains obtained during
this study will greatly contribute to the planning, immunogen selection, and analysis of vaccine-induced im-
mune responses observed during HIV-1 vaccine trials in Tanzania and neighboring countries.
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Introduction
In 2014, an estimated 1.5 million people (5.3% of the15–49-year-old age group) were living with HIV-1 in
Tanzania.1 In addition to the costs associated with treatment
and care, the loss of a significant number of adults during
their most productive years (est. 46,000 deaths among the 15–
49-year-old age group in 2014), presents a heavy burden on
the people of Tanzania. The national prevalence rates from
recent years (7% in 2004, 5.7% in 2008, and 5.1% in 2012)
suggest that the HIV-1 epidemic in Tanzania may be stabi-
lizing likely as a result of antiretroviral treatment, prevention,
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and public awareness programs that have been implemented
in various parts of the country.2–4 However, even at those
rates, the high disease burden provides incentive for Tanzania
to participate in HIV-1 vaccine trials.
The Cohort Development (CODE) study was conducted in
preparation for anticipated vaccine trials in an effort to
identify and characterize a regional cohort that had both the
need and support for an HIV-1 vaccine trial within a com-
munity cohort. The CODE study was conceived and executed
in collaboration between the Mbeya Medical Research Pro-
gramme (MMRP), U.S. Military HIV Research Program
(MHRP), Walter Reed Army Institute of Research (WRAIR),
and the University of Munich (LMU).5 CODE was con-
ducted in Mbeya Town and the nearby Itende Village, which
are in the Southwest Highlands region of Tanzania.
During recruitment for the CODE study (September 2002–
April 2003), the HIV-1 prevalence among the participants was
16.6%.5 More recent surveys4 have reported that HIV-1
prevalence in the Mbeya district dropped to 9% in 2012;
however, the three neighboring Southern/Southwestern
Highlands districts of Njombe (14.8%), Mbeya (9%), and
Iringa (9.1%) have had the highest prevalence of HIV-1 in
Tanzania for several years.2–4 The HIV-1 epidemic in Tan-
zania and East Africa in general is composed of multiple
group-M subtypes (mostly A, C, and D) and recombinants
between them. Furthermore, the HIV-1 strains that predom-
inate (pure subtype or recombinant) are known to vary from
region to region.
In northern Tanzania, a 2013 study of hospitality facility
workers and general population participants (samples col-
lected between 2008 and 2010)6 found subtype distributions
of 39% A1, 33% C, 18% D, and 11% recombinant forms.
This is in contrast to a study7 conducted in southern Tanzania,
which found subtype distributions of *8% A1, 41% C, 4%
D, and 47% recombinants among high- and low-risk partic-
ipants (samples collected in 2000). Similarly, other studies
have reported varying subtype and recombinant distributions
depending on the study location.8–10 Such variation makes a
preliminary survey of potential vaccine cohorts necessary
before immunogen selection for vaccine trials and the sub-
sequent analysis of their efficacy.
Recent HIV-1 vaccine development in Tanzania has pro-
gressed to the Phase I and II stages and has demonstrated
both safety and production of anti-HIV humoral and cellular
immune responses using a DNA prime and MVA boost
strategy11,12 that expresses various HIV-1 proteins from main
circulating subtypes and circulating recombinant form
(CRF). Currently, the HVTN 100 Phase I-II study is assessing
the safety and immunogenicity of a subtype C-oriented
vaccine within an African cohort. The HVTN 100 vaccine
contains a canarypox (ALVAC/vCP2438) vectored gp120 as
part of the prime and protein boost of two recombinant gp120
proteins, all of which are subtype C. In the event that larger
Phase III efficacy trials are conducted, a detailed molecular
analysis of the circulating strains is crucial for interpreting
vaccine-induced immune responses. Cohort characteristics
such as viral subtype distribution and the presence of local
transmission networks that may facilitate the spread of clo-
sely related strains are important attributes that are taken into
consideration during trial planning and analysis.
In this study, we present the molecular epidemiology of
incident HIV-1 strains, and the establishment of the circu-
lating recombinant form, CRF41_CD, among incident HIV-1
infections observed between 2002 and 2006 within a popu-
lation of initially seronegative participants in the prospective
CODE study conducted in Mbeya Town, Tanzania.
Materials and Methods
Study participants
In 2002–2003, the CODE study enrolled 3,096 consented
participants from Mbeya Town (urban) and neighboring
Itende Village (rural) into three subpopulations referred to
as Itende, Ghana, and Advert. Door-to-door enrollment gar-
nered 994 participants from Itende and 1,060 participants
from the Ghana ward of Mbeya Town. A second enrollment
strategy used public advertisement across all wards of Mbeya
Town to attain 1,042 participants. Following enrollment and
counseling, initial screening of the 3,096 participants re-
vealed 514 prevalent HIV-1 infections.5 The remaining 2,582
participants were followed for 3.5 years at 6-month inter-
vals to observe new HIV-1 incident infections. Of the 2,582
participants that were initially HIV-1 negative, 106 serocon-
verted during the course of this study. Plasma, mostly from
the first seropositive time point of incident infection samples,
was subjected to reverse transcription-polymerase chain re-
action (RT-PCR) and sequencing. The sequence names in-
clude a visit number (V#), which denotes the clinical visit
during which the plasma sample and subsequent HIV-1 se-
quence were obtained. Average ages described in the text
include a standard error of the mean (SEM).
Laboratory procedures
RNA extracted from plasma using the QIAamp Viral RNA
Mini Kit was the template for RT-PCR and sequencing.
Complementary DNA was synthesized as the complete ge-
nome or as two half genomes overlapping by 1.5 kb, using
ThermoScript RT (Invitrogen Corp., Carlsbad, CA) as
instructed by the manufacturer. Primer design, template
dilutions, and PCR steps were performed as previously de-
scribed.13 PCR products were then purified and sequenced
using an ABI 3100 capillary sequencer. DNA sequences were
assembled using Sequencher, version 4.7. The resulting
sequences covered HXB2 position *796–9,496 for the near
full-genome sequences and HXB2 position 4,589 or 4,950 to
9,496 for the half-genome sequences.
Phylogenetic analysis
A multiple alignment of HIV-1 reference and incident
infection strains was generated using HIVAlign14 and refined
with MEGA version 5.15 Neighbor-joining trees were con-
structed and bootstrap values were calculated with DIVEIN16
using the estimated GTR+I+G model. Informative site anal-
ysis, visual inspection, bootstrap analysis, the jumping profile
Hidden Markov Model analytical tool,17 and bootscanning
(300 nt window) were performed to precisely map break-
points within the final genome structures of inter-subtype
recombinants.18–20 Breakpoint analyses that resulted in dis-
cordant subtype assignments were resolved with HIV BLAST
(hiv.lanl.gov) analysis of the subgenomic segments. Geno-
mic pairwise distances were calculated with MEGA version
515 using the K2P model, 0.5 gamma, pairwise deletion,
and bootstrapped for 100 replications. Percent differences
374 BILLINGS ET AL.
between protein sequences were calculated with MEGA
version 5 using the p-distance model and pairwise deletion.
The median percent differences listed in the text include the
interquartile range (IQR).
Results
Study participants
The initial findings of the CODE study describing epide-
miological data on prevalent HIV-1 infections, coinfections
(STDs), sociodemographics, and sampling methods have
been previously reported.5,21 The sequenced incident infec-
tions were observed in 22 men and 35 women from the Ad-
vert and Ghana groups, and 16 men and 24 women from the
Itende group. Within the incident infections, the average age
of the infected female participants was Itende: 27.4 years
(SEM 1.5), Advert: 22.8 years (SEM 1.1), and Ghana: 21.7
years (SEM 0.9). Among the infected male participants, the
average age was Itende: 27.1 years (SEM 1.7), Advert: 25.9
years (SEM 1.8), and Ghana: 25.3 years (SEM 2.0). From the
observed incident infections, 95 near full-genome and 3 right
half-genome sequences of HIV-1 were obtained from 97
participants (includes two full-genome sequences from one
participant who displayed a change in HIV-1 genotype as the
study progressed).
HIV-1 subtype distribution
Among the incident infections, the subtype distribution
was 40% C, 17% A1, 1% D, and 42% recombinants between
parent subtypes A1, A2, C, and D. The overall subtype dis-
tribution within the incident infections did not vary sub-
stantially from the prevalent infections previously described
from this cohort (43% C, 18% A1, 3% D, and 36% recom-
binant).5 However, the location of the incident strain types
did show a higher proportion of diverse strains from recom-
binants and subtype C in the Itende (rural) subpopulation
when compared to the prevalent infections, Figure 1. Al-
though the differences were not statistically significant, the
prevalent infection phase of the study found that *30% of
the pure subtype C infections were in the rural population,
while in the incident infections nearly half of the subtype C
strains (46%) were observed in the rural group. In addition,
there were no CD recombinants among the rural prevalent
infections and only a quarter (26%) of the A1CD recombi-
nants were found in the rural population. During the incident
infection study, 75% of the CD strains and 45% of the A1CD
strains were observed in the rural group. While it should be
noted that the prevalent infection subtypes were determined
using the multi-region hybridization assay (MHA) (based on
subtype-specific probe reactivity5,22) instead of full-genome
sequencing and analysis (as with the incident infections), the
potential for inaccurate subtype assignments among the
MHA tested prevalent infections is expected to be equally
distributed among the 487 prevalent infections and should not
be biased toward a single urban or rural subpopulation.
Phylogenetic relationships between pure
and recombinant strains
The neighbor-joining tree in Figure 2 depicts the phylo-
genetic relationships between the pure and recombinant in-
cident strains from this study as well as previously identified
reference strains from East Africa deposited in GenBank. The
strains are labeled according to their visit number and sub-
population: Ghana (urban) CO0001- CO2999, Advert (ur-
ban) CO3000- CO5999, and Itende (rural) CO6000–CO6999.
In general, the pure subtype incident strains cluster with in-
terspersed reference strains from the same region, while the
recombinant incident strains mostly cluster between the pure
strains according to the relative amounts of genomic contri-
bution from their parent subtypes.
Analysis of these incident infections shows the presence of
closely related strains, two new CRF10_CD variant strains,
and revealed the emergence of a new circulating recombinant
form: CRF41_CD (see CRF41_CD section). Since this study
did not capture the HIV status of participants’ sexual con-
tacts, the closely related strains (denoted in Fig. 2) are pro-
posed as being part of local transmission networks on the
basis of having a genetic distance of 1.5% or lower, when
FIG. 1. Comparison of pure subtype and recombinant virus distribution between incident and prevalent infection phases
of the CODE study. The proportions of HIV-1 strains observed among the three subpopulations within the incident
infections are shown in (a) and the prevalent infections in (b). The crosshatched areas represent the fraction of each strain
type that was found among the urban subpopulations. CODE, cohort development. Color images available online at
www.liebertpub.com/aid
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comparing the prot-RT region23,24 between strains (HXB2
position 2262 to 3290). This stringent cutoff represents a
genetic distance well below the 99th percentile of pairwise
genetic distances for the same subgenomic region among the
pure subtype C strains (the largest sample set common to each
subpopulation in this study). General similarity searches
(HIVBLAST via the Los Alamos HIV database as of Sep-
tember 1, 2016) did not return any previously published se-
quences that would indicate these local transmission networks
extended beyond the Mbeya area. In addition, closely related
FIG. 2. Phylogenetic relationships and transmission networks between incident infection strains. Neighbor-joining tree
showing the phylogenetic relationships between incident infection strains from all three subpopulations was constructed
using the full-length genomes and pure subtype and recombinant reference sequences from the prevalent infection phase of
this study as well as regionally relevant strains. Pure subtype incident infection strains are shown in blue, recombinant
incident strains are shown in red, and reference strains are shown in black. Tree segments corresponding with pure subtype
reference strains are demarked (gray bar) and labeled according to their respective subtypes. The incident strains that
belong to proposed transmission networks were identified as having a pairwise genetic distance of <1.5% when comparing
prot-RT (HXB2 2262-3290), and are demarked with colored bars and labeled with the participant’s gender. Meaningful
bootstrap values at relevant nodes are shown. The scale bar indicates a genetic distance of 10%. Color images available
online at www.liebertpub.com/aid
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strains were confirmed by extracting, amplifying, and se-
quencing virus from plasma collected during subsequent clinic
visits by each participant. The CODE study design allowed
this strategy to be used for all study participants.
The full-length genetic distances between the incident in-
fection subtype C strains: median 10.5% (IQR 9.8%–11.1%) or
the subtype A1 strains: median 9.8% (IQR 9.2%–10.4%) are
similar to those observed within a prospective study conducted
in neighboring Kenya.13 Interestingly, we obtained two dis-
tinct recombinant strains, CO6273V3 an A1C recombinant
and CO6273V4 an A1CD recombinant, from one participant
who became multiply infected. These two strains have dif-
ferent recombinant structures and a full-length pairwise ge-
netic distance of 2.5%, which is larger than the genetic distance
between some of the related strains from different individuals.
Sequence similarity to contemporary
phase I-II HIV-1 vaccine
The ongoing HVTN 100 vaccine trial (clinicaltrials.gov/
show/NCT02404311) delivers a prime dose that containsgp120
from subtype C and parts of gag, pro, and gp41 from subtype B
(LAI). The boost dose contains recombinant gp120 from two
strains of subtype C HIV-1. All three of the gp120 immuno-
gens were derived from African subtype C strains, 96ZM651
(Zambia), TV1 (South Africa), and 1086-C (Malawi), in an
effort to produce relevant immune responses to the most pre-
dominant subtype of HIV-1 found in Africa. The percent dif-
ferences between the amino acid sequences from these gp120
immunogens and the strains observed during this study vary
depending on the extent of subtype matching, Table 1.
Compared to the incident infection strains, the vaccine im-
munogens show median percent differences of 16.6%–
17.1% to subtype C gp120 and 23.3%–23.8% to non-subtype
C gp120 (includes recombinant gp120 containing sub-
type C). These differences are comparable to the intra-subtype
differences 17% (range 4%–30%) and inter-subtype differ-
ences 25% (range 20%–36%) observed by Korber et al.25
Genomic structure of inter-subtype recombinants
Recombinant breakpoint analysis of recombinant strains
provides a useful tool for characterizing the strain diversity
within this cohort. The genomic structures of the 40 recom-
binant incident infection strains obtained during this study
are shown in Figure 3. Analysis of those strains shows that the
majority of the parent genomes are derived from subtypes
A1, C, and D with a minor contribution from sub-subtype A2
to a single recombinant. The structures contain 2–17 break-
points coming from as many as four of the parent subtypes,
although the majority are A1C recombinants.
As suggested by the extent of their relatedness (Fig. 2),
strains CO6540V3-CO6545V3 and CO6811V5-CO6975V2
have nearly identical parental subtype breakpoints within
each pair. Strains CO6273V3 and CO6273V4 were obtained
from the same participant during consecutive clinic visits and
illustrate the result of recombination between two different
recombinant strains within a single individual or limited
network of individuals. Strains CO3337V2 and CO3326V4
illustrate the result of recombination between the previously
identified CRF10_CD26 and unidentified unique recombi-
nant forms (URF), see also Supplementary Figures S1–S3
(Supplementary Data are available online at www.
liebertpub.com/aid). Strains CO6577V5, CO6650V1, and
CO6952V1 have very similar genome structures and com-
prise the proposed CRF41_CD cluster shown in Figure 2.
The average genetic distance within the CRF41_CD cluster
(0.7%) indicates recombination and dissemination across a
limited transmission network.
CRF41_CD genomic structure
and phylogenetic dissection
Recombinant breakpoint analysis was used to deter-
mine the breakpoints within strains CO6577V5, CO6650V1,
and CO6952V1. The subgenomic fragments defined by the
recombinant breakpoints were then queried against sub-
type reference strains to confirm the subtype assignments.
Figure 4 depicts the results of phylogenetic analysis of CRF41_
CD and its subgenomic fragments, and shows the bootstrap
values that support each subtype assignment. CRF41_CD
contains 9 breakpoints resulting in 10 fragments, which
alternate between subtypes C and D. The majority of CRF41_
CD is subtype D with contributions from subtype C in gag,
nef, and gp41. The assigned parent subtype of most fragments
is supported with a bootstrap value of 93 or higher. Visual
inspection identified fragment III as a poor resolution area
between subtypes C and D. Informative site analysis and
visual inspection identified fragments V and VIII as subtypes
D and C, respectively. However, the limited lengths of
those fragments prevent the attainment of significant boot-
strap values; hence, the subtype assignments of fragments V
and VIII were confirmed via BLAST analysis. Fragments II,
IV, and VI were analyzed as a contiguous fragment spanning
HXB2 nucleotide positions 1203–2162 with masking of
fragments III and V.
Discussion
The CODE study was a closed prospective cohort study
involving participants from three subpopulations located in
and around Mbeya, Tanzania. The incident infection phase of
Table 1. Median Percent Differences Between the HVTN 100 gp120 Immunogens
and the Subtype C and Non-Subtype C gp120 from the Incident Infection Strains
Vaccine
component Strain
Incident strain subtype C
gp120 median difference
(IQR), %
Incident strain non-subtype C
gp120 median difference
(IQR), %
Prime 96ZM651 16.6 (15.6–17.5) 23.8 (22.1–25.3)
Boost protein 1 TV1 17.1 (15.6–18.3) 23.5 (21.7–24.5)
Boost protein 2 1086-C 16.9 (16.2–17.9) 23.3 (22.0–24.9)
IQR, interquartile range.
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the study observed 106 new infections, from which 95 near
full-length and 3 right half-length HIV-1 sequences were
characterized. The incident infection strains identified during
the CODE study reveal the presence of pure HIV-1 subtypes
A1, C, D, a large fraction of recombinants (42%), several
distinct local transmission networks, and a new CRF. Among
the pure strains, the majority are subtype C (39%) followed by
subtype A1 (18%) with only a single subtype D. The general
pattern of pure subtype distribution within the incident infec-
tions (collected 2002–2006) is relatively unchanged compared
to the subtype distribution observed during the prevalent in-
fection phase of this study (2002), Figure 1. Likewise, the
parental nature of the incident recombinant strains also re-
sembles that seen among the prevalent infections, with the
majority of the genomic contributions coming from subtype C,
followed by subtypes A1 and D, with a small fraction of sub-
subtype A2 within a single recombinant.
Phylogenetic analysis of the incident strains confirms that
most of them are similar to previously published reference
strains from the same region (Fig. 2), which is suggestive of a
mature epidemic, in which the incident infections originate
from endemic strains within the same populace. Since the
FIG. 3. Genome structures of the 40 HIV-1 recombinant strains identified during the CODE incident infection study.
Incident recombinant genomes are depicted in relation to the HXB2 reference strain. The colored segments represent the
predicted parent subtype based on recombinant breakpoint analysis. Subtype A1 is shown in red, A2 in pink, C in yellow,
and D in blue. Color images available online at www.liebertpub.com/aid
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recombinant incident infection strains are predominantly a
mix between parent subtypes A1, C, and D, they cluster be-
tween the pure subtypes that contribute the majority of the
recombinant’s genetic materials, Figure 2. The few recom-
binant strains that do cluster among the pure subtype C strains
are primarily composed of subtype C and have genetic dis-
tances similar to the pure strains. While we do not view
the current phylogenetic analysis and its resulting trees as a
means for reproducing transmission histories or contact
networks,27,28 the viral phylogenies did indicate the presence
of closely related strain clusters worthy of further analysis via
intracluster pairwise genetic distances.
Based on pairwise genetic distance analysis, with a cutoff
of less than 1.5% in pol, six local transmission networks were
identified. The nature of HIV evolution23 (both within and
between hosts) and the lack of an external reference29 (root)
in distance defined networks, prevents determination of the
direction of transmission or whether transmission events
proceeded directly between participants or via a third party.
However, distance defined transmission networks do allow us
to recognize closely related strains and the subpopulation(s)
within which they are observed,30 Figure 2.
Of the six identified transmission networks, five of them
are from the Itende (rural) subpopulation and one is from the
Ghana ward (urban) subpopulation. This bears some con-
sideration since both the Ghana and Itende subpopulations
were recruited via a door-to-door campaign (instead of the
city-wide advertisement campaign), and since none of the
transmission networks involved study participants who
bridged separate subpopulations. Inherit limitations of this
study are the lack of comprehensive enrollment and its focus
on capturing incident infections. As a result, we are likely
FIG. 4. CRF41_CD genome structure and phylogenetic analysis of subgenome fragments. The recombinant genome of
CRF41_CD is depicted in relation to the HXB2 reference strain (top). Subgenomic fragments corresponding to parent
subtype C are shown in yellow and subtype D in blue. The phylogenetic relationship between the full-length CR41_CD
strains and subtype reference strains is shown (left). Confirmation of the parent subtypes of the subgenomic fragments is
shown using neighbor-joining trees (center) constructed from the corresponding numbered fragments of CRF41_CD (top)
and the reference strains (left). Meaningful bootstrap values at relevant nodes are shown. The scale bar indicates a genetic
distance of 10%. Color images available online at www.liebertpub.com/aid
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underreporting the number of incident infections and missing
individuals who may be associated with these transmission
networks, as well as selecting for participants with known
risk factors for HIV acquisition. Indeed, hazard analysis31 of
this incident infection study did identify several traditional
risk factors (age, education, alcohol use, and number of
lifetime sexual partners) associated with HIV infection. The
hazard analysis also identified young females from Itende as
an adjusted multivariate risk factor; however, residence lo-
cation was not an independent risk factor and there was no
significant difference in the number of observed incidence
infections between the two recruitment strategies used in
Mbeya Town.31
The presence of several transmission networks within two
of the subpopulations, but lack of transmission networks
between the subpopulations, suggests that during its 3.5-year
duration, the CODE study was able to access distinct trans-
mission dynamics within the subpopulations even though
they are neighboring areas of the same township. This was
unexpected since all three subpopulations are within walking
distance to the urban center of Mbeya Town. In that regard,
the primary differences between the transmission networks
would be the locale (urban vs. rural) and recruitment strategy
(advertisement vs. door-to-door canvassing).5,31
In both the prevalent and incident phases of this study,
the majority of the recombinant strains are URF, Figure 3.
However, within the incident phase, there were three par-
ticipants who became infected with structurally and phylo-
genetically similar strains that were identified as the new
circulating recombinant form termed CRF41_CD, Figure 4.
In addition, there were two incident strains that appeared
to be recombinants deriving from CRF10_CD (Fig. 2 and
Supplementary Figs. S1–S3) and there were two other pairs
of URFs that may lead to new CRFs in the future, Figure 3.
The substantial representation of recombinant strains within
the CODE cohort is similar to that seen in another prospective
cohort study conducted in neighboring Kenya.13 It should be
noted that while the number of URFs identified in East Africa
are abundant,5,13,32–35 very few of them have been subse-
quently observed as CRF. While this might lead to an inter-
pretation of reduced viral fitness, our study reconfirms that
URFs continue to represent a significant fraction of new in-
fections within the HIV-1 epidemic of East Africa.
In the context of vaccine development, the new CRF41_CD,
CRF10_CD variants, and the multitude of URFs represent
additional variables that may challenge the expected benefits
of a single subtype matched vaccine. Furthermore, the
CRF41_CD strains (and possibly the CRF10_CD variants)
represent known fit and infectious recombinant strains that
have the ability to transmit.
The results of the prevalent infection phase of this study
(Fig. 1) indicated that the majority of the pre-existing subtype
C and D containing strains (pure subtypes and recombinants)
were concentrated in the urban populations. The incident
infection results show an increase in the representation of
subtype D and CD containing recombinants among the rural
population, which will further complicate the therapeutic and
prophylactic vaccine options available to that group. In ad-
dition, although the three subpopulations in this study are
within walking distance to each other, the presence of sepa-
rated transmission networks suggests that the transmission
dynamics within these groups may be distinct. In the event of
large-scale (phase III) vaccine trials within Mbeya Town, the
probability of transmission between subpopulations of par-
ticipants and the nature of the circulating strains within each
group of participants will need to be considered both during
participant selection and vaccine design.
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